EDITORIALS

Paclitaxel Repackaged in an Albumin-Stabilized Nanoparticle: Handy or Just a Dandy?

Alex Sparreboom, Sharyn D. Baker, and Jaap Verweij

JCO Nov 1 2005: 7765–7767. [Full Text] [PDF]

Nanoparticle Albumin–Bound Paclitaxel for Metastatic Breast Cancer

Mark Harries, Paul Ellis, and Peter Harper

JCO Nov 1 2005: 7768–7771. First published on Oct 3 2005; 10.1200/JCO.2005.08.002. [Full Text] [PDF]

Surgical Management of BRCA1 and BRCA2 Carriers: Bitter Choices Slightly Sweetened

Wendy S. Rubinstein

JCO Nov 1 2005: 7772–7774. First published on Oct 11 2005; 10.1200/JCO.2005.07.906. [Full Text] [PDF]

Trastuzumab Cardiac Side Effects: Only Time Will Tell

Mark N. Levine

JCO Nov 1 2005: 7775–7776. [Full Text] [PDF]

Contralateral Prophylactic Mastectomy: Efficacy, Satisfaction, and Regret

Marc D. Schwartz

JCO Nov 1 2005: 7777–7779. First published on Oct 3 2005; 10.1200/JCO.2005.08.903. [Full Text] [PDF]

Fishing for New Drugs

Alan Hilary Calvert

JCO Nov 1 2005: 7780–7782. First published on Oct 3 2005; 10.1200/JCO.2005.08.004. [Full Text] [PDF]

Variations in Prostate Cancer Patterns of Care: Is It the Quality of Care or the Quality of the Data?

David F. Penson

JCO Nov 1 2005: 7783–7784. First published on Oct 11 2005; 10.1200/JCO.2005.03.0353. [Full Text] [PDF]

ORIGINAL REPORTS
Phase I and Clinical Pharmacology
	Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies
	David W. Nyman, Kimberley J. Campbell, Evan Hersh, Kristen Long, Kelly Richardson, Vuong Trieu, Neil Desai, Michael J. Hawkins, and Daniel D. Von Hoff
	JCO Nov 1 2005: 7785–7793. [Abstract] [Full Text] [PDF]

Breast Cancer
	Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
	William J. Gradishar, Sergei Tjulandin, Neville Davidson, Heather Shaw, Neil Desai, Paul Bhar, Michael Hawkins, and Joyce O'Shaughnessy
	JCO Nov 1 2005: 7794–7803. First published on Sep 19 2005; 10.1200/JCO.2005.04.937. [Abstract] [Full Text] [PDF] [Publisher's Note]
	Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
	Timothy R. Rebbeck, Tara Friebel, Theresa Wagner, Henry T. Lynch, Judy E. Garber, Mary B. Daly, Claudine Isaacs, Olufunmilayo I. Olopade, Susan L. Neuhausen, Laura van 't Veer, Rosalind Eeles, D. Gareth Evans, Gail Tomlinson, Ellen Matloff, Steven A. Narod, Andrea Eisen, Susan Domchek, Katrina Armstrong, and Barbara L. Weber
	JCO Nov 1 2005: 7804–7810. First published on Oct 11 2005; 10.1200/JCO.2004.00.8151. [Abstract] [Full Text] [PDF]
	Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31
	Elizabeth Tan-Chiu, Greg Yothers, Edward Romond, Charles E. Geyer, Jr, Michael Ewer, Deborah Keefe, Richard P. Shannon, Sandra M. Swain, Ann Brown, Louis Fehrenbacher, Victor G. Vogel, Thomas E. Seay, Priya Rastogi, Eleftherios P. Mamounas, Norman Wolmark, and John Bryant
	JCO Nov 1 2005: 7811–7819. [Abstract] [Full Text] [PDF]
	Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment
	Michael S. Ewer, Mary T. Vooletich, Jean-Bernard Durand, Myrshia L. Woods, Joseph R. Davis, Vicente Valero, and Daniel J. Lenihan
	JCO Nov 1 2005: 7820–7826. [Abstract] [Full Text] [PDF]
	Squamous Cell Carcinoma of the Breast
	Bryan T. Hennessy, Savitri Krishnamurthy, Sharon Giordano, Thomas A. Buchholz, Shu W. Kau, Zhigang Duan, Vicente Valero, and Gabriel N. Hortobagyi
	JCO Nov 1 2005: 7827–7835. [Abstract] [Full Text] [PDF]
	Breast Cancer Trends Among Black and White Women in the United States
	Ismail Jatoi, William F. Anderson, Sowmya R. Rao, and Susan S. Devesa
	JCO Nov 1 2005: 7836–7841. [Abstract] [Full Text] [PDF]
	Tamoxifen Versus Control After Adjuvant, Risk-Adapted Chemotherapy in Postmenopausal, Receptor-Negative Patients With Breast Cancer: A Randomized Trial (GABG-IV D-93)—The German Adjuvant Breast Cancer Group
	Manfred Kaufmann, Erika Graf, Walter Jonat, Wolfgang Eiermann, Matthias Geberth, Ute-Susann Albert, Günther Gademann, Bettina Conrad, Karin Stahl, Gunter von Minckwitz, and Martin Schumacher
	JCO Nov 1 2005: 7842–7848. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance
	Marlene H. Frost, Jeffrey M. Slezak, Nho V. Tran, Constance I. Williams, Joanne L. Johnson, John E. Woods, Paul M. Petty, John H. Donohue, Clive S. Grant, Jeff A. Sloan, Thomas A. Sellers, and Lynn C. Hartmann
	JCO Nov 1 2005: 7849–7856. First published on Oct 3 2005; 10.1200/JCO.2005.09.233. [Abstract] [Full Text] [PDF]
	18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes
	T. Mahfouz, M.H. Miceli, F. Saghafifar, S. Stroud, L. Jones-Jackson, R. Walker, M.L. Grazziutti, G. Purnell, A. Fassas, G. Tricot, B. Barlogie, and E. Anaissie
	JCO Nov 1 2005: 7857–7863. First published on Oct 3 2005; 10.1200/JCO.2004.00.8581. [Abstract] [Full Text] [PDF]
	Randomized Trial of Prevention of Catheter-Related Bloodstream Infection by Continuous Infusion of Low-Dose Unfractionated Heparin in Patients With Hematologic and Oncologic Disease
	Abderrahman Abdelkefi, Lamia Torjman, Saloua Ladeb, Tarek Ben Othman, Wafa Achour, Amel Lakhal, Mohamed Hsairi, Leila Kammoun, Assia Ben Hassen, and Abdeladhim Ben Abdeladhim
	JCO Nov 1 2005: 7864–7870. [Abstract] [Full Text] [PDF] [Expression of Concern]

Clinical Trials
	Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies
	Sandrine Faivre, Stéphanie Chièze, Catherine Delbaldo, Nora Ady-vago, Cecilia Guzman, Luis Lopez-Lazaro, Stéphanie Lozahic, José Jimeno, Fernando Pico, Jean Pierre Armand, José Antonio Lopez Martin, and Eric Raymond
	JCO Nov 1 2005: 7871–7880. First published on Sep 19 2005; 10.1200/JCO.2005.09.357. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Geographic and Socioeconomic Variation in the Treatment of Prostate Cancer
	Tracey L. Krupski, Lorna Kwan, Abdelmonem A. Afifi, and Mark S. Litwin
	JCO Nov 1 2005: 7881–7888. First published on Oct 3 2005; 10.1200/JCO.2005.08.755. [Abstract] [Full Text] [PDF]
	Treatment of Metastatic Renal Cell Carcinoma With a Combination of Bevacizumab and Erlotinib
	John D. Hainsworth, Jeffrey A. Sosman, David R. Spigel, Donna L. Edwards, Cara Baughman, and Anthony Greco
	JCO Nov 1 2005: 7889–7896. First published on Oct 3 2005; 10.1200/JCO.2005.01.8234. [Abstract] [Full Text] [PDF]
	Gonadotropin-Releasing Hormone Agonists and Fracture Risk: A Claims-Based Cohort Study of Men With Nonmetastatic Prostate Cancer
	Matthew R. Smith, Won Chan Lee, Jane Brandman, Qin Wang, Marc Botteman, and Chris L. Pashos
	JCO Nov 1 2005: 7897–7903. [Abstract] [Full Text] [PDF]
	Therapy Tolerance in Selected Patients With Androgen-Independent Prostate Cancer Following Strontium-89 Combined With Chemotherapy
	Shi-Ming Tu, Jeri Kim, Lance C. Pagliaro, Funda Vakar-Lopez, Frankin C. Wong, Sijin Wen, Rosales General, Donald A. Podoloff, Sue-Hwa Lin, and Christopher J. Logothetis
	JCO Nov 1 2005: 7904–7910. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Unique Gene Expression Profile Based on Pathologic Response in Epithelial Ovarian Cancer
	Dimitrios Spentzos, Douglas A. Levine, Shakirahmed Kolia, Hasan Otu, Jeff Boyd, Towia A. Libermann, and Stephen A. Cannistra
	JCO Nov 1 2005: 7911–7918. First published on Oct 3 2005; 10.1200/JCO.2005.02.9363. [Abstract] [Full Text] [PDF]
	Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian Cancer
	Usha Menon, Steven J. Skates, Sara Lewis, Adam N. Rosenthal, Barnaby Rufford, Karen Sibley, Nicola MacDonald, Anne Dawnay, Arjun Jeyarajah, Robert C. Bast, Jr, David Oram, and Ian J. Jacobs
	JCO Nov 1 2005: 7919–7926. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by Ganciclovir
	Patricia Chévez-Barrios, Murali Chintagumpala, William Mieler, Evelyn Paysse, Milton Boniuk, Claudia Kozinetz, Mary Y. Hurwitz, and Richard L. Hurwitz
	JCO Nov 1 2005: 7927–7935. [Abstract] [Full Text] [PDF]
	Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia
	Ching-Hon Pui, Deqing Pei, John T. Sandlund, Dario Campana, Raul C. Ribeiro, Bassem I. Razzouk, Jeffrey E. Rubnitz, Scott C. Howard, Nobuko Hijiya, Sima Jeha, Cheng Cheng, James R. Downing, William E. Evans, Mary V. Relling, and Melissa Hudson
	JCO Nov 1 2005: 7936–7941. [Abstract] [Full Text] [PDF]
	Long-Term Outcome in Children With Relapsed ALL by Risk-Stratified Salvage Therapy: Results of Trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 87
	Hagen Graf Einsiedel, Arend von Stackelberg, Reinhard Hartmann, Rüdiger Fengler, Martin Schrappe, Gritta Janka-Schaub, Georg Mann, Karel Hählen, Ulrich Göbel, Thomas Klingebiel, Wolf-Dieter Ludwig, and Günter Henze
	JCO Nov 1 2005: 7942–7950. [Abstract] [Full Text] [PDF]
	ß-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee
	David W. Ellison, Olabisi E. Onilude, Janet C. Lindsey, Meryl E. Lusher, Claire L. Weston, Roger E. Taylor, Andrew D. Pearson, and Steven C. Clifford
	JCO Nov 1 2005: 7951–7957. [Abstract] [Full Text] [PDF]
	Length of Stay and Mortality Associated With Febrile Neutropenia Among Children With Cancer
	Swati K. Basu, Isabel D. Fernandez, Susan G. Fisher, Barbara L. Asselin, and Gary H. Lyman
	JCO Nov 1 2005: 7958–7966. [Abstract] [Full Text] [PDF]

Genetic Testing for Cancer
	Recruiting African American Women to Participate in Hereditary Breast Cancer Research
	Chanita Hughes Halbert, Kiyona Brewster, Aliya Collier, ChaChira Smith, Lisa Kessler, Benita Weathers, Jill E. Stopfer, Susan Domchek, and E. Paul Wileyto
	JCO Nov 1 2005: 7967–7973. [Abstract] [Full Text] [PDF]

Treatment-Related Complications
	Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study
	Johanna N. Timmer-Bonte, Theo M. de Boo, Hans J. Smit, Bonne Biesma, Frank A. Wilschut, Samia A. Cheragwandi, Arien Termeer, Cornelis A. Hensing, Janine Akkermans, Eddy M. Adang, Geeben P. Bootsma, and Vivianne C. Tjan-Heijnen
	JCO Nov 1 2005: 7974–7984. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Re-Treatment With I-131 Tositumomab in Patients With Non-Hodgkin's Lymphoma Who Had Previously Responded to I-131 Tositumomab
	Mark S. Kaminski, John A. Radford, Stephanie A. Gregory, John P. Leonard, Susan J. Knox, Stewart Kroll, and Richard L. Wahl
	JCO Nov 1 2005: 7985–7993. First published on Oct 3 2005; 10.1200/JCO.2005.01.0892. [Abstract] [Full Text] [PDF]
	High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell Transplantation
	Donna L. Forrest, Donna E. Hogge, Thomas J. Nevill, Stephen H. Nantel, Michael J. Barnett, John D. Shepherd, Heather J. Sutherland, Cynthia L. Toze, Clayton A. Smith, Julye C. Lavoie, Kevin W. Song, Nicholas J. Voss, Randy D. Gascoyne, and Joseph M. Connors
	JCO Nov 1 2005: 7994–8002. First published on Oct 3 2005; 10.1200/JCO.2005.01.9083. [Abstract] [Full Text] [PDF]
	Role of Hematotoxicity and Sex in Patients With Hodgkin's Lymphoma: An Analysis From the German Hodgkin Study Group
	Beate Klimm, Thorsten Reineke, Heinz Haverkamp, Karolin Behringer, Hans T. Eich, Andreas Josting, Beate Pfistner, Volker Diehl, and Andreas Engert
	JCO Nov 1 2005: 8003–8011. First published on Oct 3 2005; 10.1200/JCO.2005.205.60. [Abstract] [Full Text] [PDF]
	Prognostic Significance of BACH2 Expression in Diffuse Large B-Cell Lymphoma: A Study of the Osaka Lymphoma Study Group
	Emiko Sakane-Ishikawa, Shin-ichi Nakatsuka, Yasuhiko Tomita, Shigeki Fujita, Itsuko Nakamichi, Tetsuya Takakuwa, Haruo Sugiyama, Shirou Fukuhara, Masayuki Hino, Akihisa Kanamaru, Toshihiro Soma, Machiko Tsukaguchi, Kazuhiko Igarashi, Yuzuru Kanakura, and Katsuyuki Aozasa
	JCO Nov 1 2005: 8012–8017. [Abstract] [Full Text] [PDF]
	Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
	Thomas Wündisch, Christian Thiede, Andrea Morgner, Astrid Dempfle, Annette Günther, Hongxiang Liu, Hongtao Ye, Ming-Qing Du, Theo D. Kim, Ekkehard Bayerdörffer, Manfred Stolte, and Andreas Neubauer
	JCO Nov 1 2005: 8018–8024. First published on Oct 3 2005; 10.1200/JCO.2005.02.3903. [Abstract] [Full Text] [PDF]

Cancer-Related Complications
	Fatigue, Menopausal Symptoms, and Cognitive Function in Women After Adjuvant Chemotherapy for Breast Cancer: 1- and 2-Year Follow-Up of a Prospective Controlled Study
	Helen G. Mar Fan, Nadine Houédé-Tchen, Qi-Long Yi, Irene Chemerynsky, Fiona P. Downie, Kathryn Sabate, and Ian F. Tannock
	JCO Nov 1 2005: 8025–8032. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
	Hedy L. Kindler, Gregory Friberg, Deepti A. Singh, Gershon Locker, Sreenivasa Nattam, Mark Kozloff, David A. Taber, Theodore Karrison, Abraham Dachman, Walter M. Stadler, and Everett E. Vokes
	JCO Nov 1 2005: 8033–8040. [Abstract] [Full Text] [PDF]

Prevention
	An Intensive Surveillance Program Detected a High Incidence of Hepatocellular Carcinoma Among Hepatitis B Virus Carriers With Abnormal Alpha-Fetoprotein Levels or Abdominal Ultrasonography Results
	Tony S.K. Mok, Winnie Yeo, Simon Yu, Paul Lai, Henry L.Y. Chan, Anthony T.C. Chan, Joseph W.Y. Lau, Herman Wong, Nancy Leung, Edwin P. Hui, Joseph Sung, Jane Koh, Frankie Mo, Benny Zee, and Philip J. Johnson
	JCO Nov 1 2005: 8041–8047. [Abstract] [Full Text] [PDF]

Melanoma
	Biologic and Prognostic Significance of Dermal Ki67 Expression, Mitoses, and Tumorigenicity in Thin Invasive Cutaneous Melanoma
	Phyllis A. Gimotty, Patricia Van Belle, David E. Elder, Todd Murry, Kathleen T. Montone, Xiaowei Xu, Susan Hotz, Shane Raines, Michael E. Ming, Peter Wahl, and DuPont Guerry
	JCO Nov 1 2005: 8048–8056. [Abstract] [Full Text] [PDF]
	Serial Monitoring of Circulating Melanoma Cells During Neoadjuvant Biochemotherapy for Stage III Melanoma: Outcome Prediction in a Multicenter Trial
	Kazuo Koyanagi, Steven J. O'Day, Rene Gonzalez, Karl Lewis, William A. Robinson, Thomas T. Amatruda, He-Jing Wang, Robert M. Elashoff, Hiroya Takeuchi, Naoyuki Umetani, and Dave S.B. Hoon
	JCO Nov 1 2005: 8057–8064. [Abstract] [Full Text] [PDF]
	A Population-Based Validation of the American Joint Committee on Cancer Melanoma Staging System
	Phyllis A. Gimotty, Jeffrey Botbyl, Seng-jaw Soong, and DuPont Guerry
	JCO Nov 1 2005: 8065–8075. [Abstract] [Full Text] [PDF]
	Variates of Survival in Metastatic Uveal Melanoma
	Petra Rietschel, Katherine S. Panageas, Christine Hanlon, Ami Patel, David H. Abramson, and Paul B. Chapman
	JCO Nov 1 2005: 8076–8080. [Abstract] [Full Text] [PDF]

Lung Cancer
	Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
	Daphne W. Bell, Thomas J. Lynch, Sara M. Haserlat, Patricia L. Harris, Ross A. Okimoto, Brian W. Brannigan, Dennis C. Sgroi, Beth Muir, Markus J. Riemenschneider, Renee Bailey Iacona, Annetta D. Krebs, David H. Johnson, Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Masahiro Fukuoka, Mark G. Kris, José Baselga, Judith S. Ochs, and Daniel A. Haber
	JCO Nov 1 2005: 8081–8092. First published on Oct 3 2005; 10.1200/JCO.2005.02.7078. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Opportunities for Targeted Therapies in Hepatocellular Carcinoma
	Melanie B. Thomas and James L. Abbruzzese
	JCO Nov 1 2005: 8093–8108. [Abstract] [Full Text] [PDF]

ART OF ONCOLOGY

The Bereaved Parent

Carolyn Russo and Alan F. Wong

JCO Nov 1 2005: 8109–8111. [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Variable Problems in Lymphomas: CASE 1. Burkitt's Lymphoma Presenting With Central Airway Obstruction

Su Pin Choo, Darren W.T. Lim, Constance P.L. Lo, Heng Nung Koong, Miriam Tao, and Chong Hee Lim

JCO Nov 1 2005: 8112–8113. [Full Text] [PDF]

Variable Problems in Lymphomas: CASE 2. Sarcoidosis Mimicking Progressive Lymphoma

Dickerman Hollister, Jr, M. Sung Lee, Richard N. Eisen, Christopher Fey, and Carol S. Portlock

JCO Nov 1 2005: 8113–8116. [Full Text] [PDF]

Variable Problems in Lymphomas: CASE 3. Spontaneous Regression of HIV-Associated Burkitt's Lymphoma of the Cecum

Samir Parekh, Tiffany Hebert, Howard Ratech, and Joseph Sparano

JCO Nov 1 2005: 8116–8117. [Full Text] [PDF]

CORRESPONDENCE

Epidermal Growth Factor Receptor Expression in Breast Cancer

Jeremy D. Karlin, Diana Nguyen, Sherry X. Yang, and Stan Lipkowitz

JCO Nov 1 2005: 8118–8119. [Full Text] [PDF]

In Reply:

Michael P. DiGiovanna, David F. Stern, Susan M. Edgerton, and Ann D. Thor

JCO Nov 1 2005: 8119–8120. [Full Text] [PDF]

Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia After Autologous Bone Marrow Transplantation: Dosis Facit Venenum?

Heinz Sill, Werner Olipitz, and Michael G. Schimek

JCO Nov 1 2005: 8120–8121. [Full Text] [PDF]

In Reply:

Jennifer R. Brown and Arnold S. Freedman

JCO Nov 1 2005: 8121–8122. [Full Text] [PDF]

Analysis of Outcome by Response Flawed

James R. Anderson and Donna S. Neuberg

JCO Nov 1 2005: 8122–8123. [Full Text] [PDF]

In Reply:

Paul Moreton

JCO Nov 1 2005: 8123–8124. [Full Text] [PDF]

Randomized Phase II Trials and Prostate-Specific Antigen Endpoints in Prostate Cancer: Much Ado About Nothing?

Walter M. Stadler, Laura C. Michaelis, and Mark J. Ratain

JCO Nov 1 2005: 8124–8125. [Full Text] [PDF]

In Reply:

Bruce J. Roth

JCO Nov 1 2005: 8125–8126. [Full Text] [PDF]

Chronic Lymphocytic Leukemia: To Transplant or Not to Transplant... That Is the Question?

Chadi Nabhan and Jacob D. Bitran

JCO Nov 1 2005: 8126–8127. [Full Text] [PDF]

In Reply:

Carol Moreno and Emili Montserrat

JCO Nov 1 2005: 8127–8128. [Full Text] [PDF]

Palliation in Incurable Head and Neck Cancers: Chemotherapy?

Gouri H. Pantvaidya, Anil K. D'cruz, and Kumar Prabhash

JCO Nov 1 2005: 8128–8129. [Full Text] [PDF]

In Reply:

Michael K. Gibson, Yi Li, Barbara Murphy, Maha H.A. Hussain, Ronald C. Deconti, John Ensley, and Arlene A. Forastiere

JCO Nov 1 2005: 8129–8130. [Full Text] [PDF]

Is Pathologic Complete Response a Valid Surrogate Parameter of Treatment Efficacy in HER2 Positive Breast Cancer Patients Undergoing Primary Chemotherapy Plus Trastuzamab?

Alfredo Berruti, Daniele Generali, Maria Pia Brizzi, Mara Ardine, Luigi Dogliotti, and Alberto Bottini

JCO Nov 1 2005: 8130–8131. [Full Text] [PDF]

In Reply:

Aman U. Buzdar, Kelly K. Hunt, Donald Berry, and Gabriel N. Hortobagyi

JCO Nov 1 2005: 8131–8132. [Full Text] [PDF]

Patients With HIV With Burkitt’s Lymphoma Have a Worse Outcome Than Those With Diffuse Large-Cell Lymphoma Also in the Highly Active Antiretroviral Therapy Era

Michele Spina, Cecilia Simonelli, Renato Talamini, and Umberto Tirelli

JCO Nov 1 2005: 8132–8133. [Full Text] [PDF]

In Reply:

Soon-Thye Lim, Roksana Karim, Bharat N. Nathwani, Anil Tulpule, and Alexandra M. Levine

JCO Nov 1 2005: 8133–8134. [Full Text] [PDF]

Incidence of Cancer in Individuals Receiving Chronic Zopiclone or Eszopiclone Requires Prospective Study

Justin Stebbing, Laura Waters, Liz Davies, Sundhiya Mandalia, Mark Nelson, Brian Gazzard, and Mark Bower

JCO Nov 1 2005: 8134–8136. [Full Text] [PDF]

Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer Patients

Christopher G. Willett, Yves Boucher, Dan G. Duda, Emmanuelle di Tomaso, Lance L. Munn, Ricky T. Tong, Sergey V. Kozin, Lucine Petit, Rakesh K. Jain, Daniel C. Chung, Dushyant V. Sahani, Sanjeeva P. Kalva, Kenneth S. Cohen, David T. Scadden, Alan J. Fischman, Jeffrey W. Clark, David P. Ryan, Andrew X. Zhu, Lawrence S. Blaszkowsky, Paul C. Shellito, Mari Mino-Kenudson, and Gregory Y. Lauwers

JCO Nov 1 2005: 8136–8139. [Full Text] [PDF]

Comprehensive Review of Chemotherapy in Patients With Metastatic Breast Cancer

Allen S. Melemed, Colleen Mockbee, and Mauro Orlando

JCO Nov 1 2005: 8139–8140. [Full Text] [PDF]

Inter-Religious Perspectives on Hope and Limits in Cancer Treatment: One Buddhist Chaplain's Response to the Case

Julia Corbett-Hemeyer

JCO Nov 1 2005: 8140–8141. [Full Text] [PDF]

ERRATUM

ERRATUM

JCO Nov 1 2005: 8142. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.